|
|
Effects of Simvastatin on Vascular Endothelial Function and Hemorheology in Patients with Coronary Heart Disease and Angina Pectoris |
LV Dan, JIN Dapeng, WANG Wenfeng, et al |
The Affiliated Hospital of Chengde Medical University, Hebei Chengde 067000, China |
|
|
Abstract Objective: To investigate the effects of simvastatin on vascular endothelial function and hemorheology in patients with coronary heart disease and angina pectoris. Methods: 84 patients with coronary heart disease and angina pectoris admitted to our hospital from January 2015 to February 2017 were selected. The patients were divided into experimental group and control group by random number table method, 42 cases in each group. Patients in the control group were treated with routine regimen, while patients in the experimental group were treated with simvastatin on the basis of routine regimen. The vascular endothelial function and hemorheological parameters were compared between the two groups. Results: After treatment, the frequency and duration of angina pectoris attacks in the experimental group were less than those in the control group (3.14 (+0.32) times/week and (3.05 (+0.46) times/min), CK-MB (32.15 (+5.32) ug/L), LDH (147.21 (+13.22) ug/L), CRP (4.02 (+0.59) mg/L and FIB (3.11 (+0.52) g/L levels were lower than those in the control group, and there were significant differences between the two groups. (P<0.05). The levels of ET (55.42 + 2.92) ng/L and TXB2 (93.23 + 6.26) ng/L in the experimental group were significantly lower than those in the control group after treatment, with a significant difference between the two groups (P<0.05). The whole blood viscosity, plasma viscosity, hematocrit and fibrinogen levels in the experimental group were significantly lower than those in the control group (P<0.05). Conclusion: Simvastatin can effectively improve vascular endothelial function and hemorheological parameters in patients with coronary heart disease and angina pectoris. It is effective and worth recommending.
|
|
|
|
|
[1] 蔡思敏.阿托伐他汀与辛伐他汀治疗冠心病合并高血脂患者的临床疗效对比分析[J].医学理论与实践,2018,31(20):3036-3038. [2] 徐春芳.阿托伐他汀与辛伐他汀对冠心病患者血脂、心绞痛发作及疼痛的影响[J].医疗装备,2018,31(19):114-115. [3] 祝志超.阿托伐他汀与辛伐他汀治疗冠心病的临床效果和安全性比较[J].基层医学论坛,2019,23(8):1105-1106. [4] 秦现彩.不稳定型心绞痛给予辛伐他汀联合氯吡格雷治疗的价值分析[J].临床研究,2018,26(09):115-116. [5] 陈元椿.美托洛尔联合辛伐他汀对冠心病心绞痛的治疗效果及对心功能、内皮功能与血脂水平的影响[J].中西医结合心脑血管病杂志,2018,16(15):2208-2211. [6] 陈玲.辛伐他汀的药理作用及临床应用效果观察[J].中国医药指南,2019,17(8):33-34. |
|
|
|